Luke O’Neill joins Open Orphan spin-off ahead of pharma firm’s IPO
Ambitions are high for Poolbeg Pharma, which will develop drugs to fight infectious diseases
Ambitions are high for Poolbeg Pharma, which will develop drugs to fight infectious diseases